When a GLP-1 receptor agonist like semaglutide crosses the blood-brain barrier and binds to receptors in these reward centers, it appears to dampen the dopamine surge associated with alcohol consumption
This powerful biological drive makes it nearly impossible to stick to a strict regimen long-term, inevitably leading to weight regain
If you choose to stop it suddenly, it might also affect your body as it is under the effects of Ozempic and will still need more time to adjust again
Instead, clinicians are entering an era where diabetes care and hepatology increasingly overlap, especially as metabolic dysfunction-associated steatotic liver disease, or MASLD, becomes Read More GLP1s and Liver Disease: Rethinking MASLD Care Beyond Obesity and A1C Jan 26, 2026 Articles, Diabetes, Featured, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 2,652 views Nonalcoholic steatohepatitis (NASH) and metabolic dysfunctionassociated steatotic liver disease (MASLD) are rapidly becoming leading causes of chronic liver disease worldwide